Bank Of America Corp Arcutis Biotherapeutics, Inc. Transaction History

Bank Of America Corp

$1.17 Trillion
Q4 2024

A detailed history of Bank Of America Corp transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 536,458 shares of ARQT stock, worth $6.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

536,458

Previous 1,175,905 54.38%

Holding current value

$6.86 Million

Previous $10.9 Million 31.67%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$8.31 - $14.99 $5.31 Million - $9.59 Million	-639,447 Reduced 54.38%	536,458 $7.47 Million
Q3 2024 Nov 14, 2024	BUY	$8.32 - $11.0 $5.07 Million - $6.7 Million	608,782 Added 107.35%	1,175,905 $10.9 Million
Q2 2024 Aug 14, 2024	SELL	$7.24 - $12.53 $2.05 Million - $3.55 Million	-283,406 Reduced 33.32%	567,123 $5.27 Million
Q1 2024 May 15, 2024	BUY	$3.25 - $11.77 $2.47 Million - $8.94 Million	759,511 Added 834.46%	850,529 $8.43 Million
Q4 2023 Feb 14, 2024	SELL	$1.84 - $4.82 $580,588 - $1.52 Million	-315,537 Reduced 77.61%	91,018 $293,000
Q2 2023 Aug 14, 2023	SELL	$7.51 - $15.0 $9.13 Million - $18.2 Million	-1,215,219 Reduced 74.93%	406,555 $3.87 Million
Q1 2023 May 12, 2023	BUY	$10.23 - $17.14 $14.1 Million - $23.7 Million	1,382,736 Added 578.46%	1,621,774 $17.8 Million
Q4 2022 Feb 10, 2023	BUY	$13.96 - $20.4 $1.23 Million - $1.79 Million	87,781 Added 58.03%	239,038 $3.54 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $2.02 Million - $3.04 Million	112,962 Added 294.98%	151,257 $2.89 Million
Q2 2022 Aug 12, 2022	BUY	$16.33 - $22.2 $462,057 - $628,149	28,295 Added 282.95%	38,295 $816,000
Q1 2022 May 16, 2022	SELL	$14.38 - $22.79 $30,341 - $48,086	-2,110 Reduced 17.42%	10,000 $193,000
Q4 2021 Feb 08, 2022	BUY	$14.98 - $25.5 $83,888 - $142,800	5,600 Added 86.02%	12,110 $251,000
Q3 2021 Nov 15, 2021	SELL	$19.28 - $27.1 $443 - $623	-23 Reduced 0.35%	6,510 $156,000
Q2 2021 Sep 13, 2021	BUY	$24.42 - $34.75 $159,535 - $227,021	6,533 New	6,533 $178,000

Others Institutions Holding ARQT

# of Institutions

217

Shares Held

129M

Call Options Held

2.02M

Put Options Held

202K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $769M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Arcutis Biotherapeutics, Inc. Transaction History